FAKTOR OPTIONSSCHEIN - QUEST DIAGNOSTICS | Delayed Deutsche Boerse AG 11:21:02 2024-07-05 am EDT | ||
| 53.42 EUR | -0.30% |
|
| Current month | +20.95% | ||
| 1 month | -18.06% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
More news
| Date | Price | Change |
|---|---|---|
| 24-07-05 | 53.42 | -0.30% |
| 24-07-04 | 53.58 | -2.39% |
| 24-07-03 | 54.89 | +19.30% |
| 24-07-02 | 46.01 | -3.74% |
| 24-07-01 | 47.8 | +7.90% |
Delayed Quote Deutsche Boerse AG
Last update July 05, 2024 at 11:21 am EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | 
BNP Paribas
|
| WKN | PG8QDG |
| ISIN | DE000PG8QDG4 |
| Date issued | 2023-11-07 |
| Strike | 140.9 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 100 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 133.1 € |
|---|---|
| Lowest since issue | 28.74 € |
| Spread | 1.69 € |
| Spread % | 3.07% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
140.9
USD
Average target price
147.7
USD
Spread / Average Target
+4.84%
- Stock Market
- Certificates
- Certificat
